s the world learns more about |
virus. One study seeks to examine how |
are coping and finding mental resilience. |
SARS-CoV-2, the virus that |
convalescent plasma— a blood byproduct |
Studies focused on similar events( SARS, |
causes COVID-19, Baylor Scott |
from recovered COVID-19 patients— can |
MERS and H1N1 outbreaks) suggest that |
& White Research Institute and Baylor |
be used to fight the disease in infected |
individuals may experience a wide range |
Scott & White Health are gathering |
patients. Another is investigating the use of |
of psychological symptoms, including |
important knowledge about the treatment |
the drug isunakinra to potentially reverse |
increased anxiety, depression and |
and possible prevention of this disease. |
complications of COVID-19 in hospitalized |
post-traumatic stress disorder. Social |
Studies sponsored by pharmaceutical |
patients with severe hyperinflammatory |
distancing, isolation and quarantine— all |
companies are helping clinicians to |
syndrome caused by the virus. |
important elements of the global plan |
understand how drugs originally created |
Other research initiatives focused |
to mitigate and reduce the spread |
for other purposes might be used to help |
on studying the immune system and its |
of infection— may result in a wide range |
people battling this virus. Baylor Scott & |
response to COVID-19 include one designed |
of psychological response. This study, |
White Research Institute activated trials |
to learn more about the antibodies |
which enrolled participants through |
at three sites, including Baylor University |
produced by the immune system when |
the MyBSWHealth app, aims to gain a |
Medical Center, for an antiviral called |
faced with COVID-19. Similarly, another |
greater understanding of the impact this |
remdesivir. The Baylor Scott & White |
study of the IMM-101, an immunity-based |
pandemic has had on mental health. |
locations were chosen to be among a |
vaccine originally developed for the |
“ It’ s so important for people to get |
select group of sites nationwide to receive |
treatment of cancer, seeks to understand |
involved and help fund studies like these,” |
doses of the drug from pharmaceutical |
its efficacy in possibly preventing and |
said Jaime Walkowiak, chief operating |
company Gilead, with the goal of seeing |
treating people with COVID-19. |
officer of Baylor Scott & White Research |
if it can improve health, and understanding |
Baylor Scott & White’ s focus is not |
Institute and chief research executive |
how long it stays in the body. Remdesivir |
solely on treatment of COVID-19 once |
of Baylor Scott & White Health.“ This |
has been shown to have promise based |
infection takes place; the research |
is exciting research that is going to |
on early reports from similar trials. It is |
program is also running multiple trials |
make an impact on the way we practice |
being studied nationwide in patients with |
looking into whether pharmaceuticals like |
healthcare going forward.” |
both moderate and severe COVID-19 |
hydroxychloroquine, a drug developed to |
|
symptoms. Other industry-sponsored |
fight malaria, is effective for healthcare |
For more information on opportunities |
trials are studying drugs that may |
workers to take to prevent the infection of |
to help fund research that will advance |
help reduce pulmonary or respiratory |
COVID-19 in their own bodies. |
care for COVID-19 and beyond, please |
inflammation among COVID-19 patients. |
Additionally, the program is committed |
contact Sarah Burdi at 214.820.4721 or |
Through generous privately funded |
to understanding the psychological impact |
Sarah. Burdi @ BSWHealth. org. If you have |
support of other studies being led |
of COVID-19 through a philanthropically |
tested positive for COVID-19 and have |
by Baylor Scott & White Research |
funded study that will help researchers |
since recovered, please contact Carter |
Institute, additional knowledge is being |
determine the enormous psychological |
Bloodcare for information about donating |
gathered and assessed to help advance |
impact this pandemic has on society, |
plasma that can possibly be used to help |
understanding of this devastating |
but more importantly, how individuals |
others struggling with the disease. |
To learn more about any Baylor Scott & White Dallas Foundation initiative, contact the Foundation at 214.820.3136 or | ||
email DallasFoundation @ BSWHealth. org. Write to us at 3600 Gaston Avenue, Barnett Tower Suite 100, Dallas, TX 75246-1800. |